Toshiba launches PROTECT program for both radiologists and patients

Published on November 26, 2012 at 4:35 AM · No Comments

To ensure the lowest possible CT radiation dose without compromising image quality, Toshiba America Medical Systems, Inc. launches PROTECT. PROTECT is a three-year, comprehensive CT radiation dose management program to help customers achieve ALARA (as low as reasonably achievable) imaging with Toshiba's AquilionTM CT product line.

PROTECT combines Toshiba's technology solutions with its renowned education and support. Through in-person collaboration, Toshiba experts will review the system's hardware and software and consider implementation of additional dose reduction technologies. These technologies include AIDR 3D, VeloCT console and leveraging Toshiba's partnerships with Radimetrics and Phoenix Technology Corporation. Toshiba's education and training will allow healthcare facilities to maximize their technology throughout its lifetime.

"Toshiba's PROTECT program benefits both radiologists and patients," said John Mycek, director, Imaging Services, Kaleida Health Care System. "The program provides us the technology, education and training to maintain diagnostic image quality while limiting the risk of dose to patients."

"As the company offering a simplified dose reduction solution for all patients across all platforms and backing it with robust training and education, PROTECT is our commitment to making CT imaging safer for all patients," said Satrajit Misra, senior director, CT Business Unit, Toshiba. "With customizable options, PROTECT is tailored to meet the specific needs of our customers."

Toshiba unveiled the PROTECT Program at the Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 25 - 30, 2012 (Booth #3438, South Hall).

Source:

Toshiba America Medical Systems, Inc.

Posted in: Device / Technology News | Healthcare News

Tags: , , , , , ,

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Tissue-engineered medical devices: an interview with Anna Wynn, Business Development Manager, Instron